Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 57 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	A Study of the Safety, and Anti-Tumor Activity of ADH300004 and 5-Fluorouracil Administered Orally in a Weekly Schedule to Subjects With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma				Phase II, Phase I				AHX-03-103 NCT00319683
	Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer				Phase II, Phase I				VU-VICC-GI-0622 VICC-GI-0622, 6980, NCI-6980, NCT00397384
	Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors				Phase II, Phase I				22706 NCT00390182
	Evaluation of Single Session Stereotactic Body Radiotherapy				Phase II, Phase I				2005-0445 NCT00492817
	Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors				Phase II, Phase I				CTCT 06-11 NCT00493883
	Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)				Phase II, Phase I				ID02-446 NCT00508443
	RAD001 in Advanced Hepatocellular Carcinoma				Phase II, Phase I				06-352 NCT00516165
	3-Dimensional Conformal Radiation Therapy, Arterial Embolization, and Tumor Cell Vaccine in Treating Patients With Unresectable, Recurrent, or Metastatic Primary Liver Cancer or Pancreatic Cancer				Phase II, Phase I				UMDNJ-0120070076 0120070076, NCT00553683
	CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma				Phase II, Phase I				2007-0248 NCT00634751
	A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma				Phase II, Phase I				HGS1012-C1077 NCT00712855


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute